Potassium;tert-butyl 4-aminopyrazole-1-carboxylate;2-[2-[2-[5-chloro-2-(1H-pyrazol-4-ylmethyl)pyrimidin-4-yl]ethyl]phenyl]propanamide;2-[2-[2-(2,5-dichloropyrimidin-4-yl)ethyl]phenyl]propanamide;2-[2-[2-(2,5-dichloropyrimidin-4-yl)ethynyl]phenyl]propanamide;2-(2-ethynylphenyl)propanamide;hydride;methane;potassiopotassium;2,4,5-trichloropyrimidine
C75H84Cl8K7N17O6 — CID 158072181
Data last refreshed: (MolForge compound catalog, from PubChem)
About Potassium;tert-butyl 4-aminopyrazole-1-carboxylate;2-[2-[2-[5-chloro-2-(1H-pyrazol-4-ylmethyl)pyrimidin-4-yl]ethyl]phenyl]propanamide;2-[2-[2-(2,5-dichloropyrimidin-4-yl)ethyl]phenyl]propanamide;2-[2-[2-(2,5-dichloropyrimidin-4-yl)ethynyl]phenyl]propanamide;2-(2-ethynylphenyl)propanamide;hydride;methane;potassiopotassium;2,4,5-trichloropyrimidine
Potassium;tert-butyl 4-aminopyrazole-1-carboxylate;2-[2-[2-[5-chloro-2-(1H-pyrazol-4-ylmethyl)pyrimidin-4-yl]ethyl]phenyl]propanamide;2-[2-[2-(2,5-dichloropyrimidin-4-yl)ethyl]phenyl]propanamide;2-[2-[2-(2,5-dichloropyrimidin-4-yl)ethynyl]phenyl]propanamide;2-(2-ethynylphenyl)propanamide;hydride;methane;potassiopotassium;2,4,5-trichloropyrimidine (PubChem CID 158072181) has the molecular formula C75H84Cl8K7N17O6 and a molecular weight of 1876.92 g/mol. Its IUPAC name is potassium;tert-butyl 4-aminopyrazole-1-carboxylate;2-[2-[2-[5-chloro-2-(1H-pyrazol-4-ylmethyl)pyrimidin-4-yl]ethyl]phenyl]propanamide;2-[2-[2-(2,5-dichloropyrimidin-4-yl)ethyl]phenyl]propanamide;2-[2-[2-(2,5-dichloropyrimidin-4-yl)ethynyl]phenyl]propanamide;2-(2-ethynylphenyl)propanamide;hydride;methane;potassiopotassium;2,4,5-trichloropyrimidine.
Molecular Properties
| Compound Name | Potassium;tert-butyl 4-aminopyrazole-1-carboxylate;2-[2-[2-[5-chloro-2-(1H-pyrazol-4-ylmethyl)pyrimidin-4-yl]ethyl]phenyl]propanamide;2-[2-[2-(2,5-dichloropyrimidin-4-yl)ethyl]phenyl]propanamide;2-[2-[2-(2,5-dichloropyrimidin-4-yl)ethynyl]phenyl]propanamide;2-(2-ethynylphenyl)propanamide;hydride;methane;potassiopotassium;2,4,5-trichloropyrimidine |
|---|---|
| PubChem CID | 158072181 |
| Molecular Formula | C75H84Cl8K7N17O6 |
| Molecular Weight | 1876.92 g/mol |
| Exact Mass | 1871.18 |
| IUPAC Name | potassium;tert-butyl 4-aminopyrazole-1-carboxylate;2-[2-[2-[5-chloro-2-(1H-pyrazol-4-ylmethyl)pyrimidin-4-yl]ethyl]phenyl]propanamide;2-[2-[2-(2,5-dichloropyrimidin-4-yl)ethyl]phenyl]propanamide;2-[2-[2-(2,5-dichloropyrimidin-4-yl)ethynyl]phenyl]propanamide;2-(2-ethynylphenyl)propanamide;hydride;methane;potassiopotassium;2,4,5-trichloropyrimidine |
| SMILES | C.C.C.C#Cc1ccccc1C(C)C(N)=O.CC(C(N)=O)c1ccccc1C#Cc1nc(Cl)ncc1Cl.CC(C(N)=O)c1ccccc1CCc1nc(Cc2cn[nH]c2)ncc1Cl.CC(C(N)=O)c1ccccc1CCc1nc(Cl)ncc1Cl.CC(C)(C)OC(=O)n1cc(N)cn1.Clc1ncc(Cl)c(Cl)n1.[H-].[K+].[K][K].[K][K].[K][K] |
| InChI | InChI=1S/C19H20ClN5O.C15H15Cl2N3O.C15H11Cl2N3O.C11H11NO.C8H13N3O2.C4HCl3N2.3CH4.7K.H/c1-12(19(21)26)15-5-3-2-4-14(15)6-7-17-16(20)11-22-18(25-17)8-13-9-23-24-10-13;2*1-9(14(18)21)11-5-3-2-4-10(11)6-7-13-12(16)8-19-15(17)20-13;1-3-9-6-4-5-7-10(9)8(2)11(12)13;1-8(2,3)13-7(12)11-5-6(9)4-10-11;5-2-1-8-4(7)9-3(2)6;;;;;;;;;;;/h2-5,9-12H,6-8H2,1H3,(H2,21,26)(H,23,24);2-5,8-9H,6-7H2,1H3,(H2,18,21);2-5,8-9H,1H3,(H2,18,21);1,4-8H,2H3,(H2,12,13);4-5H,9H2,1-3H3;1H;3*1H4;;;;;;;;/q;;;;;;;;;;;;;;;+1;-1 |
| InChIKey | XKOXCQAAVCNMMC-UHFFFAOYSA-N |
| XLogP | 10.43 |
| TPSA | 374.30 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 18 |
| Rotatable Bonds | 16 |
| Heavy Atoms | 113 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1876.92 |
| LogP ≤ 5 | 10.43 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 18 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158072181 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.